The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedicx Fund Regulatory News (MXF)

  • There is currently no data for MXF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - MedicX Fund Limited

4 Feb 2019 11:31

RNS Number : 9900O
Canaccord Genuity Limited
04 February 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MedicX Fund Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the Offeree

 

(d) Date dealing undertaken:

1 February 2019

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

Ordinary NPV

 

Buy

Sell

 

200,000

52,714

 

89p

90p

 

 

89p

88.8p

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

Date of disclosure:

4 February 2019

Contact name:

Sam Holland

Telephone number:

020 7523 8337

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREAFALEDENEFF
Date   Source Headline
23rd May 20133:30 pmRNSForm 8.3 - Assura Group Limited Replacement
23rd May 20133:05 pmRNSForm 8.3 - Assura Group Ltd
23rd May 20133:02 pmRNSForm 8.3 - Medicx Fund Ltd
23rd May 20133:00 pmRNSForm 8.3 - MedicX Fund Limited
23rd May 20131:36 pmRNSForm 8.3 - MedicX Fund Ltd
23rd May 201312:04 pmRNSForm 8.3 - MedicX Fund Limited
23rd May 201311:05 amRNSForm 8.5 (EPT/RI)
22nd May 20134:50 pmRNSScrip Calculation Price for June 2013
22nd May 20134:48 pmRNSPublication of Circular to Shareholders
22nd May 20133:21 pmRNSForm 8.3 - MedicX Fund Limited
22nd May 201311:37 amRNSForm 8.5 (EPT/RI)
22nd May 20138:51 amRNSForm 8.3 - MedicX Fund Ltd
21st May 20132:47 pmRNSForm 8.3 - MedicX Fund Limited
21st May 201311:13 amRNSForm 8.3 - MedicX Fund Limited
20th May 20133:16 pmRNSForm 8.3 - MedicX Fund Limited
20th May 20132:59 pmRNSForm 8.3 - [MedicX Fund Limited]
20th May 20132:31 pmRNSForm 8.3 - Medicx Fund Ltd
20th May 201312:56 pmRNSForm 8.3 - MedicX Fund Limited
20th May 201311:55 amRNSForm 8.5 (EPT/NON-RI)
20th May 201310:50 amRNSForm 8.5 (EPT/RI)
20th May 20139:14 amRNSForm 8.3 - MedicX Fund Ltd
20th May 20137:00 amRNSPossible offer update and Rule 2.10 disclosure
17th May 20136:24 pmRNSStatement re Possible Offer
1st May 20132:50 pmRNSNotification of Major Interest in Shares
29th Apr 20134:41 pmRNSNotice of dividend
3rd Apr 201310:05 amRNSTotal voting rights
3rd Apr 201310:02 amRNSAllotment of scrip shares to Investment Adviser
3rd Apr 201310:00 amRNSAllotment of scrip shares to Directors
26th Mar 201312:05 pmRNSScrip Dividend Declaration
25th Mar 20137:00 amRNSAcquisition of a new primary care medical centre
18th Mar 20133:45 pmRNSNotification of major interest in shares
18th Mar 20139:36 amRNSMedicX enters the EPRA Europe Index
8th Mar 20133:33 pmRNSNotification of major interest in shares
20th Feb 20135:52 pmRNSScrip Calculation Price
20th Feb 20135:49 pmRNSAnnual General Meeting results
20th Feb 20137:00 amRNSScrip Dividend Scheme
8th Feb 20139:46 amRNSInterim Management Statement
6th Feb 20136:22 pmRNSFurther re Notice of dividend
1st Feb 201312:31 pmRNSNotice of dividend
2nd Jan 20138:54 amRNSTotal voting rights
2nd Jan 20138:50 amRNSAllotment of scrip shares to Investment Adviser
2nd Jan 20138:46 amRNSAllotment of scrip shares to Directors of Company
7th Dec 20122:37 pmRNSScrip Dividend Declaration
6th Dec 20127:00 amRNS2012 Results
21st Nov 20125:52 pmRNSScrip Calculation Price for December
20th Nov 20124:50 pmRNSScrip Dividend Scheme
30th Oct 20125:11 pmRNSNotice of dividend
1st Oct 20125:07 pmRNSTotal voting rights
1st Oct 20125:00 pmRNSAllotment of scrip shares to Investment Adviser
1st Oct 20124:55 pmRNSAllotment of scrip shares to Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.